ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Scientist II or Senior Scientist at AbCellera - ApplyBlast

Scientist II or Senior Scientist

AbCellera

30 days ago

3.6 on Glassdoor

Vancouver, British Columbia, Canada

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

AbCellera is seeking a highly motivated Scientist II or Senior Scientist to join its Separation Science team in Vancouver. The role focuses on building capabilities to analyze and characterize proteins, supporting early-phase monoclonal antibody CMC programs through the development and optimization of separations-based workflows. The successful candidate will collaborate with technical teams, share expertise, and contribute to the analytical approach for CMC activities.

Responsibilities

Develop and optimize separations-based analytical methods for release testing and product characterization
Establish laboratory workflows and create best practices for the Analytical Development Separation Sciences sub-function
Collaborate with CMC technical teams to provide technical guidance and support regulatory submissions

Skills

Qualifications

PhD in biology, biochemistry, chemical biology, or a related disciplineMSc

About AbCellera

abcellera.com

Headquarters

Vancouver, British Columbia, Canada

Company Size

501-1000 employees

Founded

2012

View Profile

AbCellera is a biotechnology company that discovers and develops therapeutic antibodies using a proprietary high-throughput single‑cell screening platform combined with machine learning and large immune datasets. It partners with pharma and biotech to rapidly identify and optimize antibody leads and also advances its own pipeline of first‑in‑class and best‑in‑class programs across multiple indications and modalities. The platform is designed to accelerate target‑to‑candidate timelines and has been used in rapid-response collaborations and clinical‑stage antibody programs.